Leon McLaughlin
Family Medicine · Daphne, ALNPI 1649286188
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,300 and has fallen 97.7% since, to $30 in 2022.
Across 100 payments — averaging $17.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$241
- AstraZeneca$233
- Novo Nordisk$219
- Amgen$210
- AbbVie$103
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$88
- plus $669 from 17 others
What the payments were for
- Food & beverage$1,764100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 10 | $241 |
| AstraZeneca | 10 | $233 |
| Novo Nordisk | 18 | $219 |
| Amgen | 13 | $210 |
| AbbVie(2 entities) | 5 | $103 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $88 |
| Pfizer | 6 | $83 |
| Mylan Specialty L.p. | 1 | $72 |
| Astellas Pharma US Inc | 4 | $69 |
| Shire North American Group Inc | 5 | $68 |
| Boehringer Ingelheim | 4 | $61 |
| Novartis | 3 | $49 |
| Ironshore Pharmaceuticals Inc. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $41 |
| Neos Therapeutics, LP | 2 | $38 |
| Daiichi Sankyo Inc. | 2 | $29 |
| Avanir Pharmaceuticals, Inc. | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $12 |
| Supernus Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$100
How this compares
$1,764 in reported general payments places this provider in the 65th percentile of 1,680 family medicine providers in Alabama.
Other family medicine in Daphne
- Lashelle BarmoreBirmingham$486K
- Regina BenjaminBayou la Batre$222K
- Jonathan ParkerMuscle Shoals$214K
- Kathleen DupperHuntsville$210K
- Whitney TewHuntsville$114K
- Kelly HunterTuscaloosa$84K
- Daniel EnglertHuntsville$82K
- Joel LaughlinMobile$75K
- Ashleigh Butts-WilkersonMobile$54K
- Philip WilsonDothan$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.